Canonical Question
Drug Response Variability: Responses
Master answer
PHARMACOKINETICS
Absorption
- ↓ Oral absorption
- ↑ N/V
- ↓ gastric emptying during labour
- ↓ gastric motility 2° to intestinal compression
- ↑ gastric absorption
- ↓intestinal absorption due to ↓ intestinal blood flow
- ↑ IM/SC/transdermal absorption
- ↑ skin blood flow
- ↑ C.O. (by 30-40%)
- ↓ SVR
- ↑ skin blood flow
- IV (↑ onset)
- Neuraxial
- ↓ epidural space 2° to EDVs
- ↓ spinal and epidural doses
- Inhalational
- Progesterone-mediated ↑ MV (by 50-70%)
- ↑ FA/FI ratio (= uptake
Distribution
- ↑ VD (↑ TBW/ECF and fat)
- ↑ TBW/ECF (by 50%) (important for polar/ionized drugs)
- ↑ body fat % (important for lipid soluble drugs)
- ↓ plasma protein 2° to dilutional effect
- ↓ albumin →
- ↑ free % of acidic drugs (Eg. STP, propofol)
- ↓ dose required
- ↑ transplacental transfer of drug.
- ↓ A1AGP (by 30%) →
- ↑ free % of basic drugs (Eg. LA, β blockers)
- ↓ dose required
- ↑ transplacental transfer of drug
- ↓ albumin →
- Ionisation (mild ↑pH alters ionisation based on pKa)
- ↑ MV = mild respiratory alkalosis
- ↑ transplacental transfer of basic drugs as they will have ↑ % in unionized form
- (Base in base is less ionised)
- ↑ ion trapping in more acidotic foetal circulation
- ↑ transplacental transfer of basic drugs as they will have ↑ % in unionized form
- ↑ MV = mild respiratory alkalosis
Metabolism
- Progesterone:oestrogen ratio
- Progesterone → induces hepatic enzymes
- Oestrogen → inhibits hepatic enzymes
- ↓ plasma cholinesterase (30%)
- Placenta metabolises some drugs
- Foetal liver has functioning CYP450
- Can metabolise drugs
- But requires transfer back to maternal circ for conjugation
Excretion
- ↑ RBF/GFR (50%)
- ↑ clearance/↓ elimination t1⁄2 of water-soluble drugs
- ↑ MV/↓FRC
- ↑ washout of volatile agents
PHARMACODYNAMICS
- Decreased MAC – Increased sensitivity to volatile anaesthetics
- Increased LA sensitivity due to decreased α1-glycoprotein
- Increased sensitivity to IV anaesthetics
Gladwin 2016
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2011A Q11 | Outline the influence of pregnancy upon drug pharmacokinetics | historical_member | — |
| 2020A Q09 | Outline the changes to drug pharmacokinetics and pharmacodynamics that occur at term in pregnancy. | historical_member | — |
| 2016B Q16 | Outline the influence of pregnancy on pharmacokinetics. | historical_member | — |